| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/15/2007 | WO2007017759A2 Creating poultry and other animals resistant to viral disease |
| 02/15/2007 | WO2007017637A1 Method for producing recombinant interferon alpha-8 |
| 02/15/2007 | WO2007017635A1 Immunogenic constructs |
| 02/15/2007 | WO2007017419A2 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 02/15/2007 | WO2007017229A2 Method for carrying out the selective evolution of proteins in vitro |
| 02/15/2007 | WO2007017228A1 Methods for carrying out the selective evolution of proteins in vivo |
| 02/15/2007 | WO2007017201A1 Generation of antigen specific t cells |
| 02/15/2007 | WO2007017186A1 Herbicide tolerant cotton plants and methods for identifying same |
| 02/15/2007 | WO2007016929A1 Method for preparation of dna ladder using pcr and its optimization by numerical modeling thereof |
| 02/15/2007 | WO2007016861A1 Two-steps enzyme method for preparing 7-aminocephalosporanic acid |
| 02/15/2007 | WO2007016860A1 Escherichia coli expression vector and the uses thereof |
| 02/15/2007 | WO2007016792A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase |
| 02/15/2007 | WO2006138005A8 Genes and uses for plant improvement |
| 02/15/2007 | WO2006137064A3 Constructs and methods for generating plants exhibiting altered plasmodesmatal conductance |
| 02/15/2007 | WO2006136831A3 Gene expression technique |
| 02/15/2007 | WO2006135702A3 Methods of using redox-active surfactants to control polymer interactions |
| 02/15/2007 | WO2006128163A3 Transgenic alzheimer's mouse model vectors and uses thereof |
| 02/15/2007 | WO2006124726A3 Novel biotinylated compositions |
| 02/15/2007 | WO2006124678A3 Corn plants and seed enhanced for asparagine and protein |
| 02/15/2007 | WO2006123295A3 Dna fragments, primers, kits, and methods for amplification the detection and identification of clinically relevant candida species |
| 02/15/2007 | WO2006122650A3 Isolated aqdecay photoprotein and use thereof |
| 02/15/2007 | WO2006119458A9 Gene therapy for neurometabolic disorders |
| 02/15/2007 | WO2006108599A3 Ghrelin binding nucleic acids |
| 02/15/2007 | WO2006101983A3 Chemically inducible expression of biosynthetic pathways |
| 02/15/2007 | WO2006099615A3 Adenoviral fiber exchange shuttle system |
| 02/15/2007 | WO2006094773A3 Near reverse breeding |
| 02/15/2007 | WO2006082304A3 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 02/15/2007 | WO2006074437A8 Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same |
| 02/15/2007 | WO2006072742A3 Functional viral vectors for the overexpression or extinction of particular genes in plants, and applications thereof |
| 02/15/2007 | WO2006062928A3 Live genetically engineered protozoan vaccine |
| 02/15/2007 | WO2006060769A3 Methods and materials for expression of a recombinant protein |
| 02/15/2007 | WO2006011151A3 Vaccine comprising recombinant ct or lt toxin |
| 02/15/2007 | WO2006004955A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics and phenotypes |
| 02/15/2007 | WO2005067583A3 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 02/15/2007 | WO2005056570A3 Production of amino sugars |
| 02/15/2007 | WO2005013904A3 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 02/15/2007 | WO2005003289A8 Ap1 amine oxidase variants |
| 02/15/2007 | US20070039076 for generation of environmentally tailored crops; enhanced water and nitrogen use efficiency, cold tolerance, increased yield, enhanced seed protein and seed oil; nucleic acid molecule encoding a serine/threonine protein kinase |
| 02/15/2007 | US20070039075 Fertile transplastomic leguminous plants |
| 02/15/2007 | US20070039073 Novel synthetic genes for plant gums |
| 02/15/2007 | US20070039072 Functional and hyperfunctional siRNA |
| 02/15/2007 | US20070039071 Cell signaling genes and related methods |
| 02/15/2007 | US20070039070 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants |
| 02/15/2007 | US20070039069 Nucleic acid molecules associated with oil in plants |
| 02/15/2007 | US20070039068 High threonine producing lines of nicotiana tobacum and methods for producing |
| 02/15/2007 | US20070039066 apomictic plant containing a transgene for a desired trait and a transgene causing seed infertility; Seeds that are formed on such plants are infertile |
| 02/15/2007 | US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 02/15/2007 | US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 02/15/2007 | US20070039062 Goodpasture's syndrome model mouse |
| 02/15/2007 | US20070037770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use |
| 02/15/2007 | US20070037767 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 02/15/2007 | US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 02/15/2007 | US20070037764 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells |
| 02/15/2007 | US20070037763 Oligonucleotide compound and method for treating nidovirus infections |
| 02/15/2007 | US20070037762 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 02/15/2007 | US20070037761 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer |
| 02/15/2007 | US20070037760 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 02/15/2007 | US20070037759 Mammalian retrotransposable elements |
| 02/15/2007 | US20070037741 Novel compositions and methods for the treatment of immune related disease |
| 02/15/2007 | US20070037284 Vectors for expressing exogenous gene or exogenous nucleic acid sequences |
| 02/15/2007 | US20070037281 Method for differentiating stem cells in cells that produce a pancreatic hormone |
| 02/15/2007 | US20070037269 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 02/15/2007 | US20070037265 Genetically modified E. coli strain comprising the following modifications: inactivation or deletion of an acetate kinase gene, a fumarate reductase gene, a pyruvate formatelyase gene, an alcohol dehydrogenase gene, and a methylglyoxal synthase gene |
| 02/15/2007 | US20070037263 Novel acetoacetyl-coa reductase and process for producing optically active alcohol |
| 02/15/2007 | US20070037262 Genes encoding genetic stability, gene expression and folding proteins |
| 02/15/2007 | US20070037258 Methods and compositions for enhancing protein folding |
| 02/15/2007 | US20070037257 Nucleic acid, expression vectors and host cells for synthetic genes, chosen from a gram negative bacteria, yeast, or mammalian cell; zinc-endopeptidases that specifically cleave the synaptosomal proteins, SNAP-25, VAMP, or syntaxin at discrete sites |
| 02/15/2007 | US20070037256 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/15/2007 | US20070037254 Expression Vectors and Methods |
| 02/15/2007 | US20070037251 Novel protein expression system |
| 02/15/2007 | US20070037248 Production of modified glycoproteins having multiple antennary structures |
| 02/15/2007 | US20070037247 Polypeptide having a thermostable ribonuclease H activity; highly valuable for genetic engineering |
| 02/15/2007 | US20070037246 Methods and compositions for enhanced protein expression and purification |
| 02/15/2007 | US20070037245 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 02/15/2007 | US20070037219 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 02/15/2007 | US20070037218 Human gene critical to fertility |
| 02/15/2007 | US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 02/15/2007 | US20070037209 a fragment derived from the MET ectodomain in monomer form binds to hepatocyte growth factor/scatter factor (HGF/SF) either in the presence or absence of heparin; method for determining whether an agent binds to a MET ectodomain fragment in monomeric form |
| 02/15/2007 | US20070037199 Individual discriminating method, as well as array, apparatus and system for individual discriminating test |
| 02/15/2007 | US20070037190 DNA ligase mutants |
| 02/15/2007 | US20070037167 detecting differential gene expression of a specific nucleotide sequence that may be found in DNA, RNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides; systemic lupus erythematosis; polymerase chain reaction |
| 02/15/2007 | US20070037163 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics |
| 02/15/2007 | US20070037160 Method for the dissociation of the extracellular haemoglobin molecule of <I> arenicola marina </I> and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 02/15/2007 | US20070037158 Methods of modulating bone growth, bone remodeling and adiposity |
| 02/15/2007 | US20070037155 Having biomolecule immobilization regions of prescribed shape on a biomolecule microarray, and means by which the interaction of biomolecules is rapidly conducted, the interaction of trace quantities of sample is promoted, and the interaction is detected and analyzed rapidly and with high sensitivity |
| 02/15/2007 | US20070037154 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 02/15/2007 | US20070037151 Cd4+ human papillomavirus (hpv) epitopes |
| 02/15/2007 | US20070037149 Human calcium transporter 1 gene, screening method of calcium absorption regulating factor, and calcium absorption regulating factor |
| 02/15/2007 | US20070037148 Compositions and methods for the treatmetn of natural killer cell related diseases |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas |
| 02/15/2007 | US20070037141 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 02/15/2007 | US20070037137 Method and kit for quantitative and qualitative determination of human papillomavirus |
| 02/15/2007 | US20070036883 Plant-derived alkaline alpha-galactosidase |
| 02/15/2007 | US20070036866 Cationic block copolymers |
| 02/15/2007 | US20070036824 Optimized expression of hpv 58 l1 in yeast |
| 02/15/2007 | US20070036822 Selection system containing non-antibiotic resistance selection marker |
| 02/15/2007 | US20070036818 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 02/15/2007 | US20070036816 Tuberculosis antigen detection assays and vaccines |
| 02/15/2007 | US20070036814 Antibody binding to polypeptide of given sequence; antisera; use in wound healing, blocking adherence to indwelling medical devices, vaccines |